Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - BG Medicine, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R15.htm
EX-32 - EX-32 - BG Medicine, Inc.d398643dex32.htm
EX-10.1 - EX-10.1 - BG Medicine, Inc.d398643dex101.htm
EX-31.2 - EX-31.2 - BG Medicine, Inc.d398643dex312.htm
EX-10.2 - EX-10.2 - BG Medicine, Inc.d398643dex102.htm
10-Q - FORM 10-Q - BG Medicine, Inc.d398643d10q.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R3.htm
EX-31.1 - EX-31.1 - BG Medicine, Inc.d398643dex311.htm
v2.4.0.6
Significant Accounting Policies (Details 2)
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Options to purchase common stock [Member]
   
Common shares excluded from the computation of diluted net loss per share attributable to common stockholders    
Antidilutive securities excluded from computation of earnings per share 2,784,777 3,202,391
Common Stock Warrant Liability [Member]
   
Common shares excluded from the computation of diluted net loss per share attributable to common stockholders    
Antidilutive securities excluded from computation of earnings per share 1,086,343 1,249,001